Filing Details
- Accession Number:
- 0001567619-22-011525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 16:37:22
- Reporting Period:
- 2022-05-19
- Accepted Time:
- 2022-05-23 16:37:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1640384 | Lm Funding America Inc. | LMFA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458737 | L. Andrew Graham | 1200 Platt Street Suite 100 Tampa FL 33606 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-19 | 15,000 | $1.25 | 15,036 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-05-20 | 8,680 | $1.21 | 23,716 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $5.95 | 2031-10-28 | 12,605 | 12,605 | Direct | |
Common Stock | Stock Option (right to buy) | $500.00 | 2025-10-22 | 100 | 100 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-10-28 | 12,605 | 12,605 | Direct |
2025-10-22 | 100 | 100 | Direct |
Footnotes
- Options were granted under the LM Funding America, Inc. 2021 Omnibus Incentive Plan ("Plan"). Options will vest as to one-half of the option shares on April 26, 2022, and as to one-half of the option shares on October 28, 2022, subject to acceleration of vesting upon a Change of Control (as defined in the Plan) or upon the Issuer's common stock achieving a closing price of greater than $12.00 for 10 consecutive trading days. Notwithstanding, the options will not be exercisable unless and until the Plan is approved by the Issuer's stockholders within one year of grant date.
- This option is presently exercisable in full.